Carotid Intima‐Media Thickness Measurement Promises to Improve Cardiovascular Risk Evaluation in Head and Neck Cancer Patients. Issue 5 (11th May 2015)

• Record Type: Journal Article
• Authors: Jacoby, Douglas; Hajj, Jihane; Javaheri, Ali; deGoma, Emil; Lin, Alexander; Ahn, Peter; Quon, Harry
• Is Part Of: Clinical cardiology. Volume 38:Issue 5(2015:May)
• Page Start: 280
• Page End: 284
• Publication Date: 2015-05-11
• Subjects: Cardiology -- Periodicals; 616.12005
• DOI: 10.1002/clc.22389
• Languages: English
• ISSNs: 0160-9289

Abstract

<abstract abstract-type="main" id="clc22389-abs-0001"> <title>ABSTRACT</title> <sec id="clc22389-sec-0001" sec-type="section"> <title>Background</title> <p id="clc22389-para-0001">Radiation‐treated head and neck cancer (HNC) patients are at high risk for developing radiation vasculopathy, as evidenced by an increased stroke risk. The benefits of screening and assessing the cardiovascular (CV) risk of HNC patients using carotid intima‐media thickness (CIMT) ultrasound are not known. Our objective was to determine the prevalence of high CV risk in patients without known CV diseases who received radiation for HNC, determine the percentage of screened patients who had a change in clinical management as a result of an increased CIMT, and to compare this risk‐assessment tool to patients' risk classification using the Framingham Risk Score (FRS) and Pooled Cohort Atherosclerotic Cardiovascular Disease (ASCVD) Risk Equation (recommended by American College of Cardiology/American Heart Association Guidelines on the Assessment of Cardiovascular Risk).</p> </sec> <sec id="clc22389-sec-0002" sec-type="section"> <title>Hypothesis</title> <p id="clc22389-para-0002a">Risk calculators may not accurately predict risk in this population with a unique risk factor. Carotid IMT may be used to detect radiation vasculopathy in HNC patients.</p> </sec> <sec id="clc22389-sec-0003" sec-type="section"> <title>Methods</title> <p id="clc22389-para-0002">Retrospective medical chart review was conducted on 134 radiation‐treated HNC patients. The main outcome measures were CV risk (as determined by CIMT) and clinical management. Also, the FRS and the Pooled Cohort ASCVD Risk Equation were used to compare classification with CIMT.</p> </sec> <sec id="clc22389-sec-0004" sec-type="section"> <title>Results</title> <p id="clc22389-para-0003">Approximately 74% of the cases were at high CV risk using CIMT technique. Approximately half of the HNC patients screened had a change in clinical management characterized by recorded initiation of aspirin and recorded initiation or increase of statin therapies. The FRS and the Pooled Cohort ASCVD Risk Equation failed to detect 40% to 50% of cases found to be at high risk using the CIMT technique.</p> </sec> <sec id="clc22389-sec-0005" sec-type="section"> <title>Conclusions</title> <p id="clc22389-para-0004">Carotid IMT identified a much greater percentage of radiation‐treated HNC patients at high CV risk compared with standard CV‐risk calculators. By more accurately identifying the patients at high risk, this may lead to more effective prevention, and therefore a reduction in CV events.</p> </sec> </abstract>